Zidolam

Zidolam is a combination antiretroviral medicine used in the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection. It contains two active ingredients: zidovudine and lamivudine, both of which belong to a class of drugs called nucleoside reverse transcriptase inhibitors. Zidolam is used as part of a combination therapy to manage HIV infection, reduce viral load, and help restore and maintain immune function.

Uses:
Zidolam is used for:

The treatment of HIV-1 infection in adults and children as part of combination antiretroviral therapy.
It is often prescribed in combination with other antiretroviral medicines to improve effectiveness and reduce the risk of drug resistance.

Mechanism of Action:
Zidolam works by interfering with the ability of the HIV virus to replicate in the body:

Zidovudine is one of the earliest antiretroviral drugs and mimics a natural building block of DNA. It gets incorporated into the viral DNA chain during replication, leading to early termination and preventing further virus production.
Lamivudine works similarly by blocking the reverse transcriptase enzyme that HIV uses to convert its RNA into DNA, a key step in its replication cycle.

Adverse Effects:
Zidolam is generally effective, but some individuals may experience side effects. Common ones include: